Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Current Opinion in Nephrology and Hypertension
|
January 2, 2024
Interferon gamma in the pathogenesis of hypertension - recent insights
Lance N Benson, Shengyu Mu
Antioxidants (Basel, Switzerland)
|
April 23, 2022
Blueberry Polyphenols Increase Nitric Oxide and Attenuate Angiotensin II-Induced Oxidative Stress and Inflammatory Signaling in Human Aortic Endothelial Cells
Rami S Najjar, Shengyu Mu, Rafaela G Feresin
Current Hypertension Reports
|
July 4, 2012
The kidney and hypertension: pathogenesis of salt-sensitive hypertension
Tatsuo Shimosawa, Shengyu Mu, Shigeru Shibata, et al.
Kidney360
|
January 2, 2023
IFN-<i>γ</i> Contributes to the Immune Mechanisms of Hypertension
Lance N Benson, Yunmeng Liu, Katherine Deck, et al.
Biological Procedures Online
|
May 23, 2026
Targeting Hyaluronan Signaling Overcomes Primary Effusion Lymphoma Cells Resistance to Rapamycin
Jungang Chen, Margaret Qin, Jiaojiao Fan, et al.
Frontiers in Pharmacology
|
March 21, 2022
Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies
Soumiya Pal, Jenat Rahman, Shengyu Mu, et al.
Journal of Cancer
|
July 7, 2020
Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
Lu Dai, Jungang Chen, Zhen Lin, et al.
Frontiers in Cardiovascular Medicine
|
March 27, 2023
The link between immunity and hypertension in the kidney and heart
Lance N Benson, Yunping Guo, Katherine Deck, et al.
Plos Pathogens
|
June 1, 2026
Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation
Jungang Chen, Jiaojiao Fan, Margaret Qin, et al.
Journal of Cellular and Molecular Medicine
|
March 23, 2022
Identification of natural compounds tubercidin and lycorine HCl against small-cell lung cancer and BCAT1 as a therapeutic target
Jungang Chen, Lindsey Barrett, Zhen Lin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Current Opinion in Nephrology and Hypertension
|
January 2, 2024
Interferon gamma in the pathogenesis of hypertension - recent insights
Lance N Benson, Shengyu Mu
Antioxidants (Basel, Switzerland)
|
April 23, 2022
Blueberry Polyphenols Increase Nitric Oxide and Attenuate Angiotensin II-Induced Oxidative Stress and Inflammatory Signaling in Human Aortic Endothelial Cells
Rami S Najjar, Shengyu Mu, Rafaela G Feresin
Current Hypertension Reports
|
July 4, 2012
The kidney and hypertension: pathogenesis of salt-sensitive hypertension
Tatsuo Shimosawa, Shengyu Mu, Shigeru Shibata, et al.
Kidney360
|
January 2, 2023
IFN-<i>γ</i> Contributes to the Immune Mechanisms of Hypertension
Lance N Benson, Yunmeng Liu, Katherine Deck, et al.
Biological Procedures Online
|
May 23, 2026
Targeting Hyaluronan Signaling Overcomes Primary Effusion Lymphoma Cells Resistance to Rapamycin
Jungang Chen, Margaret Qin, Jiaojiao Fan, et al.
Frontiers in Pharmacology
|
March 21, 2022
Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies
Soumiya Pal, Jenat Rahman, Shengyu Mu, et al.
Journal of Cancer
|
July 7, 2020
Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
Lu Dai, Jungang Chen, Zhen Lin, et al.
Frontiers in Cardiovascular Medicine
|
March 27, 2023
The link between immunity and hypertension in the kidney and heart
Lance N Benson, Yunping Guo, Katherine Deck, et al.
Plos Pathogens
|
June 1, 2026
Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation
Jungang Chen, Jiaojiao Fan, Margaret Qin, et al.
Journal of Cellular and Molecular Medicine
|
March 23, 2022
Identification of natural compounds tubercidin and lycorine HCl against small-cell lung cancer and BCAT1 as a therapeutic target
Jungang Chen, Lindsey Barrett, Zhen Lin, et al.
Page
of 4